Empyrean Capital Partners’s Neogen NEOG Stock Holding History

Empyrean Capital Partners’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-93,200	Closed	-$1.3M	–	115
2022 Q3	$1.3M	Buy	+93,200	New	+$1.88M	0.04%	107

Other funds holding NEOG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Empyrean Capital Partners's NEOG Position: Q4 2022 in Review

Empyrean Capital Partners sold out of Neogen (NEOG) in Q4 2022, closing a stake of 93,200 shares — an estimated $1.3M sold.

Empyrean Capital Partners first reported a position in NEOG in Q3 2022 and held it in 1 quarter. The position peaked at $1.3M in Q3 2022. 370 funds tracked by Wall St. Rank hold NEOG as of Q4 2022.

Empyrean Capital Partners reported no remaining Neogen position as of Q4 2022 after selling out during the quarter.
Empyrean Capital Partners sold 93,200 Neogen shares in Q4 2022, an estimated $1.3M.
Empyrean Capital Partners first reported a position in Neogen in Q3 2022 and held it in 1 quarter.
Empyrean Capital Partners's Neogen position peaked at $1.3M in Q3 2022.
370 funds tracked by Wall St. Rank held Neogen as of Q4 2022.

Based on Empyrean Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.